Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:371-376
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittal, S.
Right arrow Articles by Lerman, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittal, S.
Right arrow Articles by Lerman, B. B.

CLINICAL STUDY

Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope

Suneet Mittal, MD, FACCa, Steven C. Hao, MDa, Sei Iwai, MDa, Kenneth M. Stein, MD, FACCa, Steven M. Markowitz, MD, FACCa, David J. Slotwiner, MDa and Bruce B. Lerman, MD, FACCa

a Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, New York, USA

Manuscript received July 31, 2000; revised manuscript received March 27, 2001, accepted April 10, 2001.

Reprint requests and correspondence: Dr. Bruce B. Lerman, Division of Cardiology, The New York Hospital-Cornell Medical Center, 525 East 68th Street, Starr 4, New York, New York 10021
blerman{at}med.cornell.edu

OBJECTIVES

This study was designed to determine the incidence and prognostic significance of inducible ventricular fibrillation (VF) in patients with coronary artery disease (CAD) and unexplained syncope.

BACKGROUND

Current American College of Cardiology/American Heart Association practice guidelines recommend implantation of internal cardioverter-defibrillators (ICDs) in patients with unexplained syncope in whom either ventricular tachycardia (VT) or VF is inducible during electrophysiologic (EP) testing. Although the prognostic significance of inducible monomorphic VT is known, the significance of inducible VF remains undefined.

METHODS

We evaluated 118 consecutive patients with CAD and unexplained syncope who underwent EP testing. Sustained monomorphic VT was inducible in 53 (45%) patients; in 20 (17%) patients, VF was the only inducible arrhythmia; and no sustained ventricular arrhythmia was inducible in the remaining 45 (38%) patients. The latter two groups of 65 (55%) patients make up the study population.

RESULTS

There were 16 deaths among the study population during a follow-up period of 25.3 ± 19.6 months. The overall one- and two-year survival in these patients was 89% and 81%, respectively. No significant difference in survival was observed between patients with and without inducible VF (80% power to detect a fourfold survival difference).

CONCLUSIONS

In 17% of patients with CAD and unexplained syncope, VF is the only inducible ventricular arrhythmia. Within the limits of this pilot study, long-term follow-up of patients with and without inducible VF demonstrates no difference in survival between the two groups. Therefore, the practice of ICD implantation in patients with CAD, unexplained syncope and inducible VF, especially with triple ventricular extrastimuli, may merit reconsideration.

Abbreviations and Acronyms
  AV = atrioventricular
  CAD = coronary artery disease
  EP = electrophysiologic
  ICD = implantable cardioverter-defibrillator
  LV = left ventricle, left ventricular
  LVEF = left ventricular ejection fraction
  MI = myocardial infarction
  VF = ventricular fibrillation
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
Eur Heart JHome page
Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), Endorsed by the following societies, European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al.
Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC)
Eur. Heart J., November 1, 2009; 30(21): 2631 - 2671.
[Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
M. Brignole, J.-J. Blanc, R. Sutton, and A. Moya
CHAPTER 26 Syncope
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force members, M. Brignole, P. Alboni, D. G. Benditt, L. Bergfeldt, J.-J. Blanc, P. E. B. Thomsen, J. G. van Dijk, A. Fitzpatrick, S. Hohnloser, et al.
Guidelines on management (diagnosis and treatment) of syncope - Update 2004: The task force on Syncope, European Society of Cardiology
Eur. Heart J., November 2, 2004; 25(22): 2054 - 2072.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Brembilla-Perrot, C. Suty-Selton, D. Beurrier, P. Houriez, M. Nippert, A. Terrier de la Chaise, P. Louis, O. Claudon, M. Andronache, A. Abdelaah, et al.
Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 594 - 601.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology
Europace, January 1, 2004; 6(6): 467 - 537.
[Full Text] [PDF]


Home page
EuropaceHome page
T. Pezawas, G. Stix, J. Kastner, M. Wolzt, C. Mayer, D. Moertl, and H. Schmidinger
Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantablecardioverter defibrillator therapy
Europace, January 1, 2003; 5(3): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Martinez-Rubio, J. Kuschyk, G. Sierra, G. Breithardt, and M. Borggrefe
Programmed ventricular stimulation: influence of early versus late introduction of a third extrastimulus, a randomized, prospective study
Europace, January 1, 2002; 4(1): 77 - 85.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement